332 related articles for article (PubMed ID: 19028676)
21. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface.
Makoveichuk E; Vorrsjö E; Olivecrona T; Olivecrona G
Biochem Biophys Res Commun; 2013 Nov; 441(4):941-6. PubMed ID: 24220340
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation and properties of angiopoietin-like proteins 3 and 4.
Ge H; Cha JY; Gopal H; Harp C; Yu X; Repa JJ; Li C
J Lipid Res; 2005 Jul; 46(7):1484-90. PubMed ID: 15863837
[TBL] [Abstract][Full Text] [Related]
23. Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits.
Hoffmann WG; Chen YQ; Schwartz CS; Barber JL; Dev PK; Reasons RJ; Miranda Maravi JS; Armstrong B; Gerszten RE; Silbernagel G; Konrad RJ; Bouchard C; Sarzynski MA
J Lipid Res; 2024 Feb; 65(2):100495. PubMed ID: 38160757
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
Wen Y; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
[TBL] [Abstract][Full Text] [Related]
25. Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition.
Gutgsell AR; Ghodge SV; Bowers AA; Neher SB
J Biol Chem; 2019 Feb; 294(8):2678-2689. PubMed ID: 30591589
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed.
Makoveichuk E; Sukonina V; Kroupa O; Thulin P; Ehrenborg E; Olivecrona T; Olivecrona G
Biochem Biophys Res Commun; 2012 Aug; 425(2):138-43. PubMed ID: 22820186
[TBL] [Abstract][Full Text] [Related]
27. Biochemical Analysis of the Lipoprotein Lipase Truncation Variant, LPL
Hayne CK; Lafferty MJ; Eglinger BJ; Kane JP; Neher SB
Biochemistry; 2017 Jan; 56(3):525-533. PubMed ID: 27984852
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
[TBL] [Abstract][Full Text] [Related]
29. The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.
Leth-Espensen KZ; Kristensen KK; Kumari A; Winther AL; Young SG; Jørgensen TJD; Ploug M
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723082
[TBL] [Abstract][Full Text] [Related]
30. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.
Dijk W; Beigneux AP; Larsson M; Bensadoun A; Young SG; Kersten S
J Lipid Res; 2016 Sep; 57(9):1670-83. PubMed ID: 27034464
[TBL] [Abstract][Full Text] [Related]
31. Regulation of lipoprotein lipase by Angptl4.
Dijk W; Kersten S
Trends Endocrinol Metab; 2014 Mar; 25(3):146-55. PubMed ID: 24397894
[TBL] [Abstract][Full Text] [Related]
32. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
[TBL] [Abstract][Full Text] [Related]
33. Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation.
Li J; Li L; Guo D; Li S; Zeng Y; Liu C; Fu R; Huang M; Xie W
Clin Chim Acta; 2020 Apr; 503():19-34. PubMed ID: 31923423
[TBL] [Abstract][Full Text] [Related]
34. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
Miida T; Hirayama S
Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
[TBL] [Abstract][Full Text] [Related]
35. Genetics and regulation of angiopoietin-like proteins 3 and 4.
Li C
Curr Opin Lipidol; 2006 Apr; 17(2):152-6. PubMed ID: 16531751
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in ANGPTL4 provides insights into protein processing and function.
Yin W; Romeo S; Chang S; Grishin NV; Hobbs HH; Cohen JC
J Biol Chem; 2009 May; 284(19):13213-22. PubMed ID: 19270337
[TBL] [Abstract][Full Text] [Related]
37. Not all angiopoietin-like proteins (Angptls) are created equal: insights from molecular, genetic, and pharmacological studies on the mechanism of LPL inhibition by Angptl3 and Angptl4.
Li C
Curr Opin Lipidol; 2009 Aug; 20(4):357-9. PubMed ID: 19584596
[No Abstract] [Full Text] [Related]
38. Decoding the role of angiopoietin-like protein 4/8 complex-mediated plasmin generation in the regulation of LPL activity.
Chen YQ; Zhen EY; Russell AM; Ehsani M; Siegel RW; Qian Y; Konrad RJ
J Lipid Res; 2023 Oct; 64(10):100441. PubMed ID: 37666362
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
[TBL] [Abstract][Full Text] [Related]
40. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase.
Yoshida K; Shimizugawa T; Ono M; Furukawa H
J Lipid Res; 2002 Nov; 43(11):1770-2. PubMed ID: 12401877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
